FDC
Lalit Narkhede possesses extensive experience in quality assurance within the pharmaceutical industry, currently serving as Manager Corporate Quality Assurance at FDC Limited since February 2015, after progressing through roles such as Deputy Manager and Assistant Manager. Previously, Lalit held positions at Flamingo Pharmaceutical LTD as Sr. Executive CQA and at Sandoz as QA Executive. Early career experience includes a role as Sr. Officer at Ranbaxy and as Officer at Serum Institute of India Limited. Lalit Narkhede earned a Bachelor of Pharmacy degree from Siddhant College of Pharmacy and a Diploma in Pharmacy from JSPM.
FDC
FDC Limited is a pharmaceutical company. The Company is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its therapeutic areas of focus include anti-infectives, gastrointestinals, ophthalmologicals, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology and analgesics. It has a range of functional foods and beverages. Its active pharmaceuticals ingredients (APIs) produced cover a range of therapeutic categories, such as Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate. Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm. It has multi-location manufacturing facilities for APIs, as well as finished dosage forms. Its facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh.